Evidence map›Paper›PMID 38528508›Full record

ArticleLipids in health and disease2024

Triglyceride-glucose index in early pregnancy predicts the risk of gestational diabetes: a prospective cohort study.

Yufeng Guo, Junwen Lu, Mailiman Bahani, Guifeng Ding, Lei Wang, Yuxia Zhang, Huanmei Zhang, Chengyao Liu, Lijun Zhou, Xiaolan Liu and 3 more

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Lipids in health and disease, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 38 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed, 1 pooled it
21.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 1 synthesis or guideline pooled it, 36 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Observational
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

Yufeng Guo *Department of Public Health, Xinjiang Medical University, Urumqi, Xinjiang Uygur Autonomous Region, 830000, China.
Junwen Lu *Department of Public Health, Xinjiang Medical University, Urumqi, Xinjiang Uygur Autonomous Region, 830000, China.
Mailiman Bahani *Department of Public Health, Xinjiang Medical University, Urumqi, Xinjiang Uygur Autonomous Region, 830000, China.
Guifeng DingUrumqi Maternal and Child Health Hospital, Urumqi, Xinjiang Uygur Autonomous Region, 830000, China.
Lei WangUrumqi Maternal and Child Health Hospital, Urumqi, Xinjiang Uygur Autonomous Region, 830000, China.
Yuxia ZhangUrumqi Maternal and Child Health Hospital, Urumqi, Xinjiang Uygur Autonomous Region, 830000, China.
Huanmei ZhangDepartment of Maternal and Child Nutrition, National Institute for Nutrition and Health, Chinese Center for Disease Control and Prevention, Beijing, 100050, China.
Chengyao LiuDepartment of Public Health, Xinjiang Medical University, Urumqi, Xinjiang Uygur Autonomous Region, 830000, China.
Lijun ZhouDepartment of Public Health, Xinjiang Medical University, Urumqi, Xinjiang Uygur Autonomous Region, 830000, China.
Xiaolan LiuDepartment of Public Health, Xinjiang Medical University, Urumqi, Xinjiang Uygur Autonomous Region, 830000, China.
Fangshen LiDepartment of Public Health, Xinjiang Medical University, Urumqi, Xinjiang Uygur Autonomous Region, 830000, China.
Xiaoli WangMaternal and Child Health Care Hospital of Xinjiang Uygur Autonomous Region, Urumqi, Xinjiang Uygur Autonomous Region, 830000, China.
Hong DingDepartment of Public Health, Xinjiang Medical University, Urumqi, Xinjiang Uygur Autonomous Region, 830000, China. 1045623343@qq.com.
Xinjiang Medical University · CNMaternal and Child Health Hospital of Xinjiang Uygur Autonomous Region · CNChinese Center For Disease Control and Prevention · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThis study aimed to investigate the association between the triglyceride-glucose (TyG) index in early pregnancy and the development of gestational diabetes mellitus (GDM) in the second trimester. The primary objectives were to evaluate the predictive potential of the TyG index for GDM, determine the optimal threshold value of the TyG index for GDM assessment, and compare the predictive performance of the TyG index alone versus its combination with maternal age and pre-pregnancy body mass index on GDM. Moreover, the study explored the association between the TyG index in early pregnancy and the risk of other pregnancy-related complications (PRCs), such as placental abruption and gestational hypertension. PATIENTS AND

methodsThis prospective cohort study recruited 1,624 pregnant women who underwent early pregnancy antenatal counseling and comprehensive assessments with continuous monitoring until delivery. To calculate the TyG index, health indicators, including maternal triglycerides and fasting plasma glucose, were measured in early pregnancy (< 14 weeks of gestation). The predictive power of the TyG index for evaluating GDM in Chinese pregnant women was determined using multifactorial logistic regression to derive the odds ratios and 95% confidence interval (CI). Subgroup analyses were conducted, and the efficacy of the TyG index in predicting PRCs was assessed via receiver operating characteristic (ROC) curve analysis and restricted cubic spline, with the optimal cutoff value calculated.

resultsLogistic regression analyses revealed a 2.10-fold increase in the GDM risk for every 1-unit increase in the TyG index, after adjusting for covariates. The highest GDM risk was observed in the group with the highest TyG index compared with the lowest quintile group (odds ratios: 3.25; 95% CI: 2.23-4.75). Subgroup analyses indicated that exceeding the recommended range of gestational weight gain and an increased GDM risk were significantly associated (P = 0.001). Regarding predictive performance, the TyG index exhibited the highest area under the curve (AUC) value in the ROC curve for GDM (AUC: 0.641, 95% CI: 0.61-0.671). The optimal cutoff value was 8.890, with both sensitivity and specificity of 0.617.The combination of the TyG index, maternal age, and pre-pregnancy body mass index proved to be a superior predictor of GDM than the TyG index alone (AUC: 0.672 vs. 0.641, P < 0.01). After adjusting for multiple factors, the analyses indicated that the TyG index was associated with an increased risk of gestational hypertension. However, no significant association was noted between the TyG index and the risk of preeclampsia, placental abruption, intrauterine distress, or premature rupture of membranes.

conclusionThe TyG index can effectively identify the occurrence of GDM in the second trimester, aligning with previous research. Incorporating the TyG index into routine clinical assessments of maternal health holds significant practical implications. Early identification of high-risk groups enables healthcare providers to implement timely interventions, such as increased monitoring frequency for high-risk pregnant women and personalized nutritional counseling and health education. These measures can help prevent or alleviate potential maternal and infant complications, thereby enhancing the overall health outcomes for both mothers and babies.

Indexed as

Abruptio PlacentaeDiabetes, GestationalHypertension, Pregnancy-InducedBlood GlucoseBody Mass IndexFemaleGlucoseHumansPlacentaPregnancyProspective StudiesTriglyceridesBlood GlucoseGlucoseTriglyceridesEarly pregnancyGestational diabetes mellitusPregnancy-related complicationsSingleton pregnancyTriglyceride-glucose index

Identifiers

PMID38528508
PMCPMC10962154
OpenAlexW4393155167

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.